Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bisphosphonates in oncology: update 2007].

K Zaman1, L Favet, C Schusterbauer

  • 1Centre pluridisciplinaire, d'oncologie (CePO), CHUV, 101 1 Lausanne. Khalil.Zaman@chuv.ch

Revue Medicale Suisse
|June 29, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Long-term immunity and IgG subclass response following Hepatitis E vaccination: A longitudinal cohort study in Matlab, Bangladesh.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Frequency of Congenital Hypothyroidism and Radiographic Assessment of Knee Epiphysis in Newborn.

Mymensingh medical journal : MMJ·2025
Same author

Comparative Epidemiology of Salmonella enterica Serovers Paratyphi A and Typhi Causing Enteric Fever, Bangladesh, 2018-2020.

Emerging infectious diseases·2025
Same author

Cellular and Humoral Immune Profiles After Hepatitis E Vaccination and Infection.

Viruses·2025

Bisphosphonates effectively prevent bone issues in cancer patients. However, severe side effects and better cancer treatments now question their widespread use, necessitating careful patient selection and limited administration durations.

Area of Science:

  • Oncology
  • Pharmacology
  • Bone Metabolism

Context:

  • Bisphosphonates are widely used to prevent skeletal-related events in cancer patients.
  • International guidelines have supported their extensive use due to perceived low toxicity.
  • Recent concerns regarding late-onset severe toxicity, such as osteonecrosis of the jaw, have emerged.

Purpose:

  • To re-evaluate the risk/benefit ratio of bisphosphonate therapy in cancer care.
  • To address the lack of monitoring methods for bisphosphonate treatment.
  • To propose strategies for safer and more effective use of bisphosphonates.

Summary:

  • Bisphosphonates, while effective against cancer-induced bone complications, face scrutiny due to severe toxicities like osteonecrosis of the jaw.

Related Experiment Videos

  • Advancements in oncologic therapies reduce the relative benefit of bisphosphonates.
  • The absence of a monitoring method for bisphosphonate therapy complicates risk management.

    • Impact:

    • Highlights the need for stricter patient selection based on established indications.
    • Recommends limiting the duration of bisphosphonate administration to optimize the risk/benefit balance.
    • Informs clinical practice regarding the evolving role and management of bisphosphonates in cancer treatment.